EA202190954A1 - Гуманизированное моноклональное антитело против n-укороченного бета-амилоида - Google Patents
Гуманизированное моноклональное антитело против n-укороченного бета-амилоидаInfo
- Publication number
- EA202190954A1 EA202190954A1 EA202190954A EA202190954A EA202190954A1 EA 202190954 A1 EA202190954 A1 EA 202190954A1 EA 202190954 A EA202190954 A EA 202190954A EA 202190954 A EA202190954 A EA 202190954A EA 202190954 A1 EA202190954 A1 EA 202190954A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- amyloid
- trunctioned
- beta
- monoclonal antibody
- antibody against
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- Hospice & Palliative Care (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Настоящее изобретение относится к гуманизированным антителам, которые связываются с амилоидными пептидами, причем антитела содержат мутации в вариабельных доменах тяжелой цепи и/или легкой цепи, которые улучшают связывающую активность. Антитела могут быть полезны при лечении болезни Альцгеймера (AD, БА).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201816210 | 2018-10-04 | ||
PCT/EP2019/076772 WO2020070225A1 (en) | 2018-10-04 | 2019-10-02 | Humanised anti-n-truncated amyloid beta monoclonal antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202190954A1 true EA202190954A1 (ru) | 2021-06-29 |
Family
ID=68136417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202190954A EA202190954A1 (ru) | 2018-10-04 | 2019-10-02 | Гуманизированное моноклональное антитело против n-укороченного бета-амилоида |
Country Status (13)
Country | Link |
---|---|
US (1) | US20230203140A9 (ru) |
EP (1) | EP3861023A1 (ru) |
JP (1) | JP2022513331A (ru) |
KR (1) | KR20210080400A (ru) |
CN (1) | CN113056480A (ru) |
AU (1) | AU2019354714A1 (ru) |
BR (1) | BR112021006153A2 (ru) |
CA (1) | CA3114669A1 (ru) |
EA (1) | EA202190954A1 (ru) |
IL (1) | IL281979A (ru) |
MX (1) | MX2021003867A (ru) |
SG (1) | SG11202102765RA (ru) |
WO (1) | WO2020070225A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL296322A (en) | 2020-03-10 | 2022-11-01 | Lifearc | Cyclic peptides |
WO2024133925A1 (en) | 2022-12-22 | 2024-06-27 | Bioarctic Ab | Antibody which binds to abetape3 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US474900A (en) | 1892-05-17 | William byrnes | ||
US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
EP0832981A1 (en) | 1987-02-17 | 1998-04-01 | Pharming B.V. | DNA sequences to target proteins to the mammary gland for efficient secretion |
US5633076A (en) | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
SG177954A1 (en) * | 2007-01-05 | 2012-02-28 | Univ Zuerich | Method of providing disease-specific binding molecules and targets |
EP2576617B1 (en) * | 2010-06-04 | 2016-04-27 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Universitätsmedizin | MONOCLONAL ANTIBODIES TARGETING Aß OLIGOMERS |
EP2847217B1 (en) * | 2012-05-10 | 2017-10-11 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin | CONFORMATIONAL-SPECIFIC ANTIBODIES AGAINST OLIGOMERS of Amyloid beta |
US20150320706A1 (en) * | 2014-05-12 | 2015-11-12 | Chiesi Farmaceutici S.P.A. | Formulations and methods of treating alzheimer's disease and other proteinopathies by combination therapy |
EA038120B1 (ru) * | 2015-07-16 | 2021-07-08 | Пробайодраг Аг | Гуманизированные антитела к пироглутаматному варианту бета-амилоида |
CN111518206B (zh) * | 2019-02-01 | 2022-03-29 | 长春金赛药业有限责任公司 | 人源化抗Aβ单克隆抗体及其应用 |
IL296322A (en) * | 2020-03-10 | 2022-11-01 | Lifearc | Cyclic peptides |
-
2019
- 2019-10-02 CN CN201980065883.5A patent/CN113056480A/zh active Pending
- 2019-10-02 AU AU2019354714A patent/AU2019354714A1/en active Pending
- 2019-10-02 BR BR112021006153-3A patent/BR112021006153A2/pt unknown
- 2019-10-02 US US17/282,592 patent/US20230203140A9/en active Pending
- 2019-10-02 KR KR1020217012796A patent/KR20210080400A/ko active Search and Examination
- 2019-10-02 EA EA202190954A patent/EA202190954A1/ru unknown
- 2019-10-02 WO PCT/EP2019/076772 patent/WO2020070225A1/en unknown
- 2019-10-02 EP EP19782593.8A patent/EP3861023A1/en active Pending
- 2019-10-02 CA CA3114669A patent/CA3114669A1/en active Pending
- 2019-10-02 JP JP2021543565A patent/JP2022513331A/ja active Pending
- 2019-10-02 MX MX2021003867A patent/MX2021003867A/es unknown
- 2019-10-02 SG SG11202102765RA patent/SG11202102765RA/en unknown
-
2021
- 2021-04-01 IL IL281979A patent/IL281979A/en unknown
Also Published As
Publication number | Publication date |
---|---|
SG11202102765RA (en) | 2021-04-29 |
EP3861023A1 (en) | 2021-08-11 |
CA3114669A1 (en) | 2020-04-09 |
IL281979A (en) | 2021-05-31 |
CN113056480A (zh) | 2021-06-29 |
US20210347867A1 (en) | 2021-11-11 |
MX2021003867A (es) | 2021-09-08 |
US20230203140A9 (en) | 2023-06-29 |
AU2019354714A1 (en) | 2021-04-29 |
JP2022513331A (ja) | 2022-02-07 |
KR20210080400A (ko) | 2021-06-30 |
WO2020070225A1 (en) | 2020-04-09 |
BR112021006153A2 (pt) | 2021-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA202092825A1 (ru) | Анти-sirpa антитела и способы их применения | |
EA202092933A1 (ru) | Антитела к entpd2, виды комбинированной терапии и способы применения антител и видов комбинированной терапии | |
EA201891909A1 (ru) | TGFβ1-СВЯЗЫВАЮЩИЕ ИММУНОГЛОБУЛИНЫ И ИХ ПРИМЕНЕНИЕ | |
EA201270813A1 (ru) | АНТИТЕЛА К N3pGlu БЕТА-АМИЛОИДНОМУ ПЕПТИДУ И ИХ ПРИМЕНЕНИЕ | |
EA202092847A1 (ru) | Антитела к cd3 и их применение | |
EA201792221A1 (ru) | Антитела против сортилина и способы их применения | |
MX2019012868A (es) | Anticuerpos anti-trem2 y metodos para utilizarlos. | |
EA201790342A1 (ru) | Антитела к trem2 и способы их применения | |
EA202190138A1 (ru) | Анти-sirp-бета1 антитела и способы их использования | |
EA202091130A1 (ru) | Лиофилизованный препарат моноклонального антитела к транстиретину | |
NZ594682A (en) | Fully human antibodies specific to cadm1 | |
EA202092420A1 (ru) | Антитело против pd-l1 и его применение | |
EA202190235A1 (ru) | Антитела к cd33 и способы их применения | |
MX2022009915A (es) | Anticuerpos anti-ror2, fragmentos de anticuerpos, sus inmunoconjugados y usos de los mismos. | |
EA202190183A1 (ru) | Антитела к siglec-5 и способы их применения | |
EA201992206A1 (ru) | Моноклональное антитело к pd-l1 | |
EA201990895A1 (ru) | Антитела к о1 и варианты их применения | |
EA202092085A1 (ru) | ТЕРАПЕВТИЧЕСКИЕ АНТИТЕЛА ПРОТИВ sPLA2-GIB И ИХ ПРИМЕНЕНИЕ | |
EA202192810A1 (ru) | АНТИТЕЛА К PcrV, КОТОРЫЕ СВЯЗЫВАЮТ PcrV, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ АНТИТЕЛА К PcrV, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
EA202190954A1 (ru) | Гуманизированное моноклональное антитело против n-укороченного бета-амилоида | |
EA201992688A1 (ru) | Средства, пути применения и способы лечения | |
BR112021018632A2 (pt) | Moléculas de ligação ao cd3 | |
EA202092595A1 (ru) | Антитела к siglec-7 и способы их применения | |
EA201691414A1 (ru) | Антитела к матриксной металлопротеиназе 9 и способы их применения | |
EA201891800A1 (ru) | Антитела к цитруллинированным hla-полипептидам и их применение |